Prospective	O
study	O
of	O
dietary	B:C0012155
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
on	O
the	O
risk	O
of	O
hip	O
fracture	I:C0019557
in	O
the	O
elderly	O
.	O

Prospective	O
study	O
of	O
dietary	O
Non	B:C4049177
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
on	O
the	O
risk	O
of	O
hip	O
fracture	I:C0019557
in	O
the	O
elderly	O
.	O

Prospective	O
study	O
of	O
dietary	O
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
on	O
the	O
risk	O
of	O
hip	B:C0019557
fracture	I:C0019557
in	O
the	O
elderly	O
.	O

Prospective	O
study	O
of	O
dietary	O
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
on	O
the	O
risk	O
of	O
hip	O
fracture	I:C0019557
in	O
the	O
elderly	B:C0001792
.	O

Dietary	B:C0729311
antioxidants	I:C0729311
may	O
play	O
an	O
important	O
role	O
in	O
the	O
prevention	O
of	O
bone	O
loss	I:C0029453
and	O
associated	O
fractures	O
by	O
reducing	O
levels	O
of	O
oxidative	O
stress	I:C0242606
.	O

Dietary	O
antioxidants	I:C0729311
may	O
play	O
an	O
important	O
role	O
in	O
the	O
prevention	O
of	O
bone	B:C0029453
loss	I:C0029453
and	O
associated	O
fractures	O
by	O
reducing	O
levels	O
of	O
oxidative	O
stress	I:C0242606
.	O

Dietary	O
antioxidants	I:C0729311
may	O
play	O
an	O
important	O
role	O
in	O
the	O
prevention	O
of	O
bone	O
loss	I:C0029453
and	O
associated	O
fractures	B:C0016658
by	O
reducing	O
levels	O
of	O
oxidative	O
stress	I:C0242606
.	O

Dietary	O
antioxidants	I:C0729311
may	O
play	O
an	O
important	O
role	O
in	O
the	O
prevention	O
of	O
bone	O
loss	I:C0029453
and	O
associated	O
fractures	O
by	O
reducing	O
levels	O
of	O
oxidative	B:C0242606
stress	I:C0242606
.	O

We	O
prospectively	O
investigated	O
the	O
association	O
between	O
dietary	B:C0012155
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
(	O
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
)	O
and	O
the	O
risk	O
of	O
hip	O
fracture	I:C0019557
and	O
whether	O
this	O
effect	O
was	O
modified	O
by	O
smoking	O
.	O

We	O
prospectively	O
investigated	O
the	O
association	O
between	O
dietary	O
Non	B:C4049177
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
(	O
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
)	O
and	O
the	O
risk	O
of	O
hip	O
fracture	I:C0019557
and	O
whether	O
this	O
effect	O
was	O
modified	O
by	O
smoking	O
.	O

We	O
prospectively	O
investigated	O
the	O
association	O
between	O
dietary	O
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
(	O
Non	B:C4049177
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
)	O
and	O
the	O
risk	O
of	O
hip	O
fracture	I:C0019557
and	O
whether	O
this	O
effect	O
was	O
modified	O
by	O
smoking	O
.	O

We	O
prospectively	O
investigated	O
the	O
association	O
between	O
dietary	O
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
(	O
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
)	O
and	O
the	O
risk	O
of	O
hip	B:C0019557
fracture	I:C0019557
and	O
whether	O
this	O
effect	O
was	O
modified	O
by	O
smoking	O
.	O

In	O
the	O
Swedish	B:C0599755
National	I:C0599755
March	I:C0599755
Cohort	I:C0599755
13,409	O
men	O
and	O
women	O
over	O
the	O
age	O
of	O
55	O
who	O
had	O
not	O
experienced	O
cancer	O
,	O
cardiovascular	O
disease	I:C0007222
or	O
hip	O
fracture	I:C0019557
,	O
were	O
followed	O
through	O
record	O
-	I:C0025101
linkages	I:C0025101
from	O
1997	O
through	O
2010	O
.	O

In	O
the	O
Swedish	O
National	I:C0599755
March	I:C0599755
Cohort	I:C0599755
13,409	O
men	B:C0025266
and	O
women	O
over	O
the	O
age	O
of	O
55	O
who	O
had	O
not	O
experienced	O
cancer	O
,	O
cardiovascular	O
disease	I:C0007222
or	O
hip	O
fracture	I:C0019557
,	O
were	O
followed	O
through	O
record	O
-	I:C0025101
linkages	I:C0025101
from	O
1997	O
through	O
2010	O
.	O

In	O
the	O
Swedish	O
National	I:C0599755
March	I:C0599755
Cohort	I:C0599755
13,409	O
men	O
and	O
women	B:C0043210
over	O
the	O
age	O
of	O
55	O
who	O
had	O
not	O
experienced	O
cancer	O
,	O
cardiovascular	O
disease	I:C0007222
or	O
hip	O
fracture	I:C0019557
,	O
were	O
followed	O
through	O
record	O
-	I:C0025101
linkages	I:C0025101
from	O
1997	O
through	O
2010	O
.	O

In	O
the	O
Swedish	O
National	I:C0599755
March	I:C0599755
Cohort	I:C0599755
13,409	O
men	O
and	O
women	O
over	O
the	O
age	O
of	O
55	O
who	O
had	O
not	O
experienced	O
cancer	B:C0006826
,	O
cardiovascular	O
disease	I:C0007222
or	O
hip	O
fracture	I:C0019557
,	O
were	O
followed	O
through	O
record	O
-	I:C0025101
linkages	I:C0025101
from	O
1997	O
through	O
2010	O
.	O

In	O
the	O
Swedish	O
National	I:C0599755
March	I:C0599755
Cohort	I:C0599755
13,409	O
men	O
and	O
women	O
over	O
the	O
age	O
of	O
55	O
who	O
had	O
not	O
experienced	O
cancer	O
,	O
cardiovascular	B:C0007222
disease	I:C0007222
or	O
hip	O
fracture	I:C0019557
,	O
were	O
followed	O
through	O
record	O
-	I:C0025101
linkages	I:C0025101
from	O
1997	O
through	O
2010	O
.	O

In	O
the	O
Swedish	O
National	I:C0599755
March	I:C0599755
Cohort	I:C0599755
13,409	O
men	O
and	O
women	O
over	O
the	O
age	O
of	O
55	O
who	O
had	O
not	O
experienced	O
cancer	O
,	O
cardiovascular	O
disease	I:C0007222
or	O
hip	B:C0019557
fracture	I:C0019557
,	O
were	O
followed	O
through	O
record	O
-	I:C0025101
linkages	I:C0025101
from	O
1997	O
through	O
2010	O
.	O

In	O
the	O
Swedish	O
National	I:C0599755
March	I:C0599755
Cohort	I:C0599755
13,409	O
men	O
and	O
women	O
over	O
the	O
age	O
of	O
55	O
who	O
had	O
not	O
experienced	O
cancer	O
,	O
cardiovascular	O
disease	I:C0007222
or	O
hip	O
fracture	I:C0019557
,	O
were	O
followed	O
through	O
record	B:C0025101
-	I:C0025101
linkages	I:C0025101
from	O
1997	O
through	O
2010	O
.	O

Non	B:C4049177
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
was	O
assessed	O
by	O
a	O
validated	O
food	O
frequency	I:C2986698
questionnaire	I:C2986698
collected	O
at	O
baseline	O
.	O

Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
was	O
assessed	O
by	O
a	O
validated	O
food	B:C2986698
frequency	I:C2986698
questionnaire	I:C2986698
collected	O
at	O
baseline	O
.	O

We	O
categorized	O
the	O
distribution	O
of	O
Non	B:C4049177
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
into	O
sex	O
-	O
specific	O
quartiles	O
and	O
used	O
multivariable	O
adjusted	I:C0033489
Cox	I:C0033489
proportional	I:C0033489
hazards	I:C0033489
regression	I:C0033489
models	I:C0033489
to	O
estimate	O
hazard	O
ratios	O
(	O
HRs	O
)	O
with	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CI	O
)	O
.	O

We	O
categorized	O
the	O
distribution	O
of	O
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
into	O
sex	O
-	O
specific	O
quartiles	O
and	O
used	O
multivariable	B:C0033489
adjusted	I:C0033489
Cox	I:C0033489
proportional	I:C0033489
hazards	I:C0033489
regression	I:C0033489
models	I:C0033489
to	O
estimate	O
hazard	O
ratios	O
(	O
HRs	O
)	O
with	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CI	O
)	O
.	O

During	O
a	O
mean	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
time	O
of	O
12.4	O
years	O
,	O
we	O
identified	O
491	O
incident	O
cases	O
of	O
first	O
hip	O
fracture	I:C0019557
.	O

During	O
a	O
mean	O
follow	O
-	I:C1522577
up	I:C1522577
time	O
of	O
12.4	O
years	O
,	O
we	O
identified	O
491	O
incident	O
cases	O
of	O
first	O
hip	B:C0019557
fracture	I:C0019557
.	O

Subjects	O
in	O
the	O
highest	O
quartile	O
of	O
dietary	B:C0012155
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
had	O
a	O
39	O
%	O
lower	O
risk	O
of	O
incident	O
hip	O
fracture	I:C0019557
compared	O
to	O
those	O
in	O
the	O
lowest	O
quartile	O
(	O
HR	O
:	O
0.61	O
;	O
95	O
%	O
CI	O
:	O
0.44-0.85	O
)	O
.	O

Subjects	O
in	O
the	O
highest	O
quartile	O
of	O
dietary	O
Non	B:C4049177
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
had	O
a	O
39	O
%	O
lower	O
risk	O
of	O
incident	O
hip	O
fracture	I:C0019557
compared	O
to	O
those	O
in	O
the	O
lowest	O
quartile	O
(	O
HR	O
:	O
0.61	O
;	O
95	O
%	O
CI	O
:	O
0.44-0.85	O
)	O
.	O

Subjects	O
in	O
the	O
highest	O
quartile	O
of	O
dietary	O
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
had	O
a	O
39	O
%	O
lower	O
risk	O
of	O
incident	O
hip	B:C0019557
fracture	I:C0019557
compared	O
to	O
those	O
in	O
the	O
lowest	O
quartile	O
(	O
HR	O
:	O
0.61	O
;	O
95	O
%	O
CI	O
:	O
0.44-0.85	O
)	O
.	O

The	O
association	O
was	O
non-linear	O
(	O
p	O
for	O
non-linearity	O
:	O
0.004	O
)	O
with	O
a	O
potential	O
threshold	O
between	O
the	O
first	O
and	O
the	O
second	O
quartile	O
and	O
no	O
further	O
risk	O
reduction	O
at	O
higher	O
levels	O
of	O
dietary	B:C0012155
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
.	O

The	O
association	O
was	O
non-linear	O
(	O
p	O
for	O
non-linearity	O
:	O
0.004	O
)	O
with	O
a	O
potential	O
threshold	O
between	O
the	O
first	O
and	O
the	O
second	O
quartile	O
and	O
no	O
further	O
risk	O
reduction	O
at	O
higher	O
levels	O
of	O
dietary	O
Non	B:C4049177
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
.	O

Due	O
to	O
a	O
low	O
smoking	O
prevalence	O
in	O
our	O
study	O
population	O
,	O
we	O
had	O
limited	O
power	O
to	O
detect	O
effect	O
modification	O
between	O
dietary	B:C0012155
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
and	O
smoking	O
on	O
a	O
multiplicative	O
or	O
additive	O
scale	O
.	O

Due	O
to	O
a	O
low	O
smoking	O
prevalence	O
in	O
our	O
study	O
population	O
,	O
we	O
had	O
limited	O
power	O
to	O
detect	O
effect	O
modification	O
between	O
dietary	O
Non	B:C4049177
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
and	O
smoking	O
on	O
a	O
multiplicative	O
or	O
additive	O
scale	O
.	O

Higher	O
dietary	O
Non	B:C4049177
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
intake	O
is	O
associated	O
with	O
lower	O
risk	O
of	O
hip	O
fracture	I:C0019557
in	O
the	O
elderly	O
.	O

Higher	O
dietary	O
Non	O
Enzymatic	I:C4049177
Antioxidant	I:C4049177
Capacity	I:C4049177
intake	O
is	O
associated	O
with	O
lower	O
risk	O
of	O
hip	B:C0019557
fracture	I:C0019557
in	O
the	O
elderly	O
.	O

